Microbot Medical Inc.
MBOT
$2.61
$0.187.41%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 53.45% | 2.15% | -15.38% | -24.00% | -24.70% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 17.96% | -5.45% | -19.33% | -28.44% | -25.80% |
| Operating Income | -17.96% | 5.45% | 19.33% | 28.44% | 25.80% |
| Income Before Tax | -6.55% | -5.87% | 10.08% | 20.06% | 18.44% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -6.55% | -5.87% | 10.08% | 20.06% | 18.44% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.55% | -5.87% | 10.08% | 20.06% | 18.44% |
| EBIT | -17.96% | 5.45% | 19.33% | 28.44% | 25.80% |
| EBITDA | -18.31% | 5.47% | 19.41% | 28.70% | 26.03% |
| EPS Basic | 32.66% | 33.75% | 45.31% | 48.30% | 40.64% |
| Normalized Basic EPS | 26.24% | 41.55% | 51.63% | 53.73% | 45.79% |
| EPS Diluted | 32.79% | 33.86% | 45.37% | 48.35% | 40.42% |
| Normalized Diluted EPS | 26.24% | 41.55% | 51.63% | 53.73% | 45.79% |
| Average Basic Shares Outstanding | 53.49% | 56.17% | 63.72% | 56.29% | 40.35% |
| Average Diluted Shares Outstanding | 53.49% | 56.17% | 63.72% | 56.29% | 40.35% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |